Company profile
Neonc Technologies Holdings, Inc.
NASDAQ: NTHI · Healthcare · Biotechnology
#1093 of 1,422 Healthcare companies by revenuebottom-quartile growth
EA Score
10DFH 6DQ 12GM —SS 28
v0.1 · 55/100 weight · provisional
↑ market scale, filing timeliness · ↓ disclosure history, operating margin
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$62.1M
Employees
5
as of 2026-08-18
Market cap
$137.2M
as of 2026-08-18
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$40.0k$40.0k2025
Net income-$62.1M-$62.1M2025
Operating income-$58.2M-$58.2M2025
Total assets$2.8M$2.8M2025
Liabilities$20.3M$20.3M2025
Equity-$17.5M-$17.5M2025
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Neonc Technologies Holdings, Inc.’s revenue?
Neonc Technologies Holdings, Inc. booked $40.0k in FY2025 revenue, contracting 52% year over year — slower than 82% of Healthcare companies we track, at a -155404.4% net margin.
Peers · Healthcare
Calidi Biotherapeutics, Inc.19DMillennium Sustainable Ventures Corp.——Altimmune, Inc.55CAXIM Biotechnologies, Inc.——AREV Life Sciences Global Corp——Oragenics, Inc.46DNeighbors
Los Angeles →Key facts
CEOAmir Farrokh Heshmatpour
SectorHealthcare
IndustryBiotechnology
HeadquartersCalabasas, CA
ExchangeNASDAQ: NTHI
Employees5
IPO date2025-03-26
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.